Every record from Janoshik · page 33
The single largest contributor to the index and the de facto reference against which the other five labs are calibrated here. Measured offset against the reference laboratory is 0.000 pp. Full laboratory profile →
| Report | Compound | Supplier | Lot | Quarter | Purity % | Water % | Recovery % | Provenance | Flags | Result |
|---|---|---|---|---|---|---|---|---|---|---|
| AX-2025-018665 | BPC-157 | QYB | QYB-2508-M5929 | 2025-Q4 | 99.63 | 4.18 | — | Laboratory-retained | 1 | MARGINAL |
| AX-2025-020918 | Pemvidutide | CPC | CPC-2507-H2201 | 2025-Q4 | 98.17 | 3.53 | 103.8 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-020146 | CJC-1295 (no DAC) | GGPeps | GGPE-2507-D8658 | 2025-Q4 | 98.22 | 3.96 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019895 | Selank | SWB | SWB-2511-C5170 | 2025-Q4 | 99.11 | 8.59 | 102.8 | Supplier-supplied | 0 | PASS |
| AX-2025-019720 | L-Glutathione (reduced) | HJ | HJ-2507-P3062 | 2025-Q4 | 99.26 | 7.05 | 88.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019438 | Melanotan II | Homopeptide | HOMO-2505-N9201 | 2025-Q4 | 99.01 | 2.82 | 93.3 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019405 | Tirzepatide | Homopeptide | HOMO-2510-E8656 | 2025-Q4 | 97.74 | 4.59 | 106.8 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-019053 | SS-31 (Elamipretide) | JEEP | JEEP-2511-B3061 | 2025-Q4 | 99.46 | 5.26 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020465 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.28 | 5.39 | 107.1 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020001 | CJC-1295 with DAC | ERP | ERP-2507-A6393 | 2025-Q4 | 99.05 | 3.99 | 107.3 | Buyer-sourced | 1 | MARGINAL |
| AX-2025-019836 | IGF-1 LR3 | SWB | SWB-2510-U5063 | 2025-Q4 | 98.19 | 5.65 | 97.0 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018713 | GHRP-6 | QSC | QSC-2508-F6725 | 2025-Q4 | 99.93 | 4.84 | 102.2 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021111 | TB-500 | WXT | WXT-2507-J5534 | 2025-Q4 | 98.30 | 3.01 | — | Supplier-supplied | 2 | FAIL |
| AX-2025-020149 | MGF | GGPeps | GGPE-2506-T9249 | 2025-Q4 | 98.34 | 3.70 | — | Supplier-supplied | 0 | PASS |
| AX-2025-019645 | Semaglutide | Homopeptide | HOMO-2508-K2535 | 2025-Q4 | 98.99 | 4.04 | — | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019585 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 6.02 | 99.7 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019447 | GHRP-2 | Homopeptide | HOMO-2505-T8504 | 2025-Q4 | 99.22 | 4.58 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018774 | Survodutide | QSC | QSC-2506-B8101 | 2025-Q4 | 98.97 | 6.55 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021112 | TB-500 | WXT | WXT-2507-J5534 | 2025-Q4 | 97.96 | 3.68 | 99.1 | Supplier-supplied | 2 | FAIL |
| AX-2025-020833 | SS-31 (Elamipretide) | SGN | SGN-2507-U1475 | 2025-Q4 | 96.77 | 4.18 | 103.7 | Buyer-sourced | 0 | FAIL |
| AX-2025-020632 | Semaglutide | SSA | SSA-2510-C7247 | 2025-Q4 | 98.77 | 3.68 | 94.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-020444 | KPV | KP | KP-2509-N5148 | 2025-Q4 | 98.99 | 2.35 | — | Supplier-supplied | 1 | FAIL |
| AX-2025-019184 | AOD-9604 | TFC | TFC-2511-L5476 | 2025-Q4 | 99.64 | 3.18 | 95.2 | Supplier-supplied | 0 | PASS |
| AX-2025-020832 | SS-31 (Elamipretide) | SGN | SGN-2507-U1475 | 2025-Q4 | 96.89 | 3.98 | 104.4 | Supplier-supplied | 0 | FAIL |
| AX-2025-019633 | Semaglutide | Homopeptide | HOMO-2505-N2173 | 2025-Q4 | 99.30 | 5.57 | 106.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018887 | Ipamorelin | QSC | QSC-2508-X9836 | 2025-Q4 | 99.40 | 2.91 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-019664 | SS-31 (Elamipretide) | Homopeptide | HOMO-2507-B2039 | 2025-Q4 | 98.85 | 5.70 | 88.7 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019593 | GHRP-6 | Homopeptide | HOMO-2508-W1724 | 2025-Q4 | 99.93 | 6.13 | — | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018838 | Tirzepatide | QSC | QSC-2510-D8660 | 2025-Q4 | 99.57 | 3.35 | 92.4 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-018490 | CJC-1295 with DAC | WWB | WWB-2509-J2816 | 2025-Q4 | 99.40 | 3.68 | 101.1 | Supplier-supplied | 1 | MARGINAL |
| AX-2025-021128 | Semaglutide | WXT | WXT-2509-A5382 | 2025-Q4 | 97.87 | 6.61 | 104.1 | Laboratory-retained | 1 | MARGINAL |
| AX-2025-021118 | TB-500 | WXT | WXT-2507-J5534 | 2025-Q4 | 98.28 | 3.35 | 96.4 | Supplier-supplied | 2 | FAIL |
| AX-2025-020581 | PEG-MGF | SSA | SSA-2505-U6896 | 2025-Q4 | 95.65 | 2.50 | — | Supplier-supplied | 0 | PASS |
| AX-2025-020147 | CJC-1295 (no DAC) | GGPeps | GGPE-2507-D8658 | 2025-Q4 | 99.06 | 3.67 | 96.8 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019578 | Semaglutide | Homopeptide | HOMO-2509-F1941 | 2025-Q4 | 99.31 | 5.34 | 89.9 | Buyer-sourced | 2 | MARGINAL |
| AX-2025-020466 | BPC-157 | KP | KP-2511-M5346 | 2025-Q4 | 98.46 | 5.03 | 96.9 | Supplier-supplied | 2 | MARGINAL |
| AX-2025-019023 | N-Acetyl Semax Amide | JEEP | JEEP-2507-U3035 | 2025-Q4 | 99.93 | 8.53 | 99.8 | Supplier-supplied | 0 | PASS |
| AX-2025-018580 | BPC-157 | QYB | QYB-2506-B4999 | 2025-Q4 | 99.93 | 5.13 | 88.4 | Supplier-supplied | 3 | MARGINAL |
| AX-2025-021109 | TB-500 | WXT | WXT-2507-J5534 | 2025-Q4 | 97.40 | 3.53 | — | Buyer-sourced | 2 | FAIL |
| AX-2025-020913 | Pemvidutide | CPC | CPC-2507-H2201 | 2025-Q4 | 97.93 | 4.02 | 90.7 | Buyer-sourced | 3 | MARGINAL |